Dana-Farber Cancer Institute and Department of Radiology, Harvard Medical School, Boston, MA
The Dana-Farber Cancer Institute (DFCI), in affiliation with Harvard Medical School, is seeking a Radiologist with expertise in molecular cancer imaging to lead DFCI's translational research program, with an appointment as an Assistant or Associate Professor of Radiology at Harvard Medical School. A track record in translational molecular imaging using novel and traditional approaches is required. Of particular interest to the institution would be a track record of translational research using novel imaging approaches to diagnose cancer early and track response to novel therapies in humans.
A generous package of research support will be provided for successful candidates to allow his/her research to thrive in a nurturing academic and clinical environment. DFCI offers outstanding, state-of-the-art facilities to conduct this research program, including, among others, the Molecular Cancer Imaging Facility (MCIF), housing a fully staffed preclinical cyclotron facility, and the Lurie Cancer Imaging Facility (LCIF), housing small animal imaging PET/CT, SPECT/CT, high-field small animal imaging MRI and optical (bioluminescence) and hybrid optical-ultrasound (multispectral optoacoustic imaging, MSOT) as well as state-of-the-art Raman spectroscopy imaging systems. In addition, the MCIF cyclotron facility is currently in the process of being upgraded to a GMP-grade facility, which will then offer both preclinical and immediate clinical translational radiotracer syntheses. The program will also be supported by the GMP grade radiochemistry facilities and cyclotron at BWH to support clinical trials. This program will also have full access to other relevant BWH research facilities, including the Advanced Multimodality Image Guided Operating (AMIGO) suite, the clinical translational test-bed for research in BWH's National Center for Image-Guided Therapy (NCIGT).
Candidates should have an M.D. or M.D./Ph.D. degree, be board certified in Diagnostic Radiology, and ideally also in Nuclear Medicine. A proven track record of high caliber publications and successful grant applications is expected. Excellent communication and leadership skills and team-building and collaborative efforts are required.
DFCI Radiologists are part of the BWH Physician's Organization, which offers competitive salaries and an outstanding personal and professional benefits package.
All application materials, including CV and a letter describing qualifications, as well as three professional references that we will contact directly to provide reference letters, should be submitted via e-mail to the search committee chair: Marcelo F. Di Carli, MD (firstname.lastname@example.org); please cc both Erin M. Foley (ErinM_Foley@dfci.harvard.edu) and Ashley Watterson (Ashley_Watterson@dfci.harvard.edu) on the email. Questions regarding the position can also be submitted to Moritz_Kircher@dfci.harvard.edu (Chair, DFCI Department of Imaging). Dana-Farber Cancer Institute and Brigham and Women’s Hospital are equal opportunity employers and affirm the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.
Internal Number: 1234
About Dana-Farber Cancer Institute
The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.